Mucosis' Grant - II Round

Mucosis raised a round of funding on September 25, 2012. Investors include Eurostars Programme.

Mucosis is a clinical-stage Dutch biotechnology company with a proprietary platform technology, Mimopath, on which it develops novel vaccines using various routes of administration including those tha…

Articles about Mucosis' Grant - II Round: